Active	Status	Sponsor type	Region	Phase	Filter
7 Active 1 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hu, James
INVINCIBLE-3, NCT06263231: A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults with Soft Tissue Sarcomas	Recruiting	3	333	Europe, Canada, US	INT230-6, Eribulin, Trabectedin, Pazopanib	Intensity Therapeutics, Inc., Premier Research Group plc	Sarcoma,Soft Tissue	12/27	12/28
NCT03604783: Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors	Terminated	1	74	US	TP-1287	Sumitomo Pharma America, Inc.	Advanced Solid Tumors, Sarcoma, Ewing Sarcoma, Dedifferentiated Liposarcoma, Synovial Sarcoma	01/24	01/24